barium has been researched along with sr 95531 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guyenet, PG; Hayar, A | 1 |
1 other study(ies) available for barium and sr 95531
| Article | Year |
|---|---|
Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Baclofen; Barium; Benzazepines; Bridged Bicyclo Compounds; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; Glycine Agents; Heptanes; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Kinetics; Ligands; Medulla Oblongata; Neurons; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Strychnine | 2000 |